-
Product Insights
ASF Group – The Peninsula Hope Island Community – Queensland
Equip yourself with the essential tools needed to make informed and profitable decisions with our ASF Group - The Peninsula Hope Island Community - Queensland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Levalbuterol Sulfate in Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Levalbuterol Sulfate in Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE)Drug Details:Levalbuterol sulfate (ASF-1096)...
-
Sector Analysis
Portugal Insurance Industry – Governance, Risk and Compliance
Portugal Insurance Industry Report Overview The Portugal insurance industry is regulated mainly by the Insurance and Pension Fund Supervision Authority (ASF). Other regulatory bodies that oversee the operations are the International Association of Insurance Supervisors (IAIS), the European Insurance and Occupational Pensions Authority (EIOPA), the Federation of European Risk Management Associations (FERMA), and the Portuguese Association of Insurers (APS). The Portugal insurance industry research report provides a detailed analysis of the insurance regulations for life, property, motor, liability, personal accident,...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – levalbuterol sulfate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry levalbuterol sulfate Drug Details Levalbuterol sulfate (ASF-1096) is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.